(Note: I now also wrote up this blog post as a commentary that I submitted to the editor of the journal.) The very short answer is: no, youth mental health… Read more »
There has been a 60 year long discussion on the role of the neurotransmitter serotonin in the pathophysiology of depression. A recent systematic investigation by Joanna Moncrieff and colleagues concluded… Read more »
TL;DR: Mental disorders are commonly defined as “brain disorders” in the literature, and the current funding structure in psychiatry and clinical psychology is strongly based on this notion. At least… Read more »
On December 15th, Molecular Psychiatry published our commentary “The volumes of subcortical regions in depressed and healthy individuals are strikingly similar: a reinterpretation of the results by Schmaal et al”…. Read more »
Halaris and colleagues published a paper in the Journal of Psychiatric Research in which they studied the impact of the SSRI antidepressant escitalopram (ESC) in a group of 30 depressed… Read more »
Imagine you are the editor of, or reviewer for, a very prestigious scientific journal, and you receive a paper about the efficacy of a novel drug for, say, cancer or… Read more »
Nature didn’t want our commentary ;) … so we publish it here instead. A commentary by Eiko Fried, Sophie van der Sluis, and Angelique Cramer (PDF) A recent study published in… Read more »
Our commentary regarding the NIMH’s decision to solely fund research investigating the neurobiological roots of mental disorders was published in today’s issue of Nature. » Fried, E. I., Tuerlinckx, F.,… Read more »